Advertisement
Screener

ALPINE IMMUNE SCIENCES, INC. Patents: Applications Pending, 2021

ALPINE IMMUNE SCIENCES, INC. Patent Applications Pending

8 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2021-11-10: Application 63278072; Invention METHODS OF DOSING AND TREATMENT WITH A TACI-FC FUSION IMMUNOMODULATORY PROTEIN; Applicant Alpine Immune Sciences, Inc.; Status Provisional Application Expired.
  • 2021-10-15: Application 63256505; Invention METHODS OF DOSING AND TREATMENT WITH A TACI-FC FUSION IMMUNOMODULATORY PROTEIN; Applicant Alpine Immune Sciences, Inc.; Status Provisional Application Expired.
  • 2021-10-14: Application 17603827; Invention METHODS AND USES OF VARIANT ICOS LIGAND (ICOSL) FUSION PROTEINS; Applicant Alpine Immune Sciences, Inc.; Status Response to Non-Final Office Action Entered and Forwarded to Examiner.
  • 2021-09-01: Application 63239899; Invention METHODS OF DOSING AND TREATMENT WITH A TACI-FC FUSION IMMUNOMODULATORY PROTEIN; Applicant Alpine Immune Sciences, Inc.; Status Provisional Application Expired.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2021-11-1063278072METHODS OF DOSING AND TREATMENT WITH A TACI-FC FUSION IMMUNOMODULATORY PROTEINAlpine Immune Sciences, Inc.Provisional Application Expired
Stacey DILLON
Jing YANG
Stanford L. PENG
United States
United States
United States
2021-10-1563256505METHODS OF DOSING AND TREATMENT WITH A TACI-FC FUSION IMMUNOMODULATORY PROTEINAlpine Immune Sciences, Inc.Provisional Application Expired
Stacey DILLON
Jing YANG
Stanford L. PENG
United States
United States
United States
2021-10-1417603827METHODS AND USES OF VARIANT ICOS LIGAND (ICOSL) FUSION PROTEINSAlpine Immune Sciences, Inc.Response to Non-Final Office Action Entered and Forwarded to ExaminerUS20220218785A1
Ryan SWANSON
Jing YANG
Stanford PENG
Jan HILLSON
United States
United States
United States
United States
STONEBRAKER, ALYSSA RAE
2021-09-0163239899METHODS OF DOSING AND TREATMENT WITH A TACI-FC FUSION IMMUNOMODULATORY PROTEINAlpine Immune Sciences, Inc.Provisional Application Expired
Stacey DILLON
Jing YANG
Stanford L. PENG
United States
United States
United States
2021-05-07PCTUS2021031432APRIL AND BAFF INHIBITORY IMMUNOMODULATORY PROTEINS WITH AND WITHOUT A T CELL INHIBITORY PROTEIN AND METHODS OF USE THEREOFALPINE IMMUNE SCIENCES, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
STACEY DILLON
MARK RIXON
LAWRENCE EVANS
RYAN SWANSON
JOSEPH L. KUIJPER
STANFORD L. PENG
DANIEL WILLIAM DEMONTE
United States
United States
United States
United States
United States
United States
United States
2021-05-07PCTUS2021031430APRIL AND BAFF INHIBITORY IMMUNOMODULATORY PROTEINS AND METHODS OF USE THEREOFALPINE IMMUNE SCIENCES, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
STACEY DILLON
MARK RIXON
STANFORD L. PENG
DANIEL WILLIAM DEMONTE
JOSEPH L. KUIJPER
LAWRENCE EVANS
United States
United States
United States
United States
United States
United States
2021-05-0763186027METHODS OF DOSING AND TREATMENT WITH A TACI-FC FUSION IMMUNOMODULATORY PROTEINAlpine Immune Sciences, Inc.Provisional Application Expired
Stacey DILLON
Jing YANG
Stanford L. PENG
United States
United States
United States
2021-03-1117275646METHODS AND USES OF VARIANT CD80 FUSION PROTEINS AND RELATED CONSTRUCTSAlpine Immune Sciences, Inc.Docketed New Case - Ready for ExaminationUS20220177587A1
Ryan SWANSON
Mark F. MAURER
Stanford L. PENG
Jing YANG
Kristine M. SWIDEREK
United States
United States
United States
United States
United States
PETRASH, HILARY ANN